SONA shaved off close to 60% off its recent highs after news of 2 week delay for FDA approval of their COVID-19 test kits. Nothing has changed fundamentally and, if you read the NR carefully, they are lining up more customers and shipping kit prototypes under research license. NASDAQ uplisting is pending as well. The stock has landed in the historical support zone, almost exactly at EMA 50. Additional Fib support right below. This is a good speculative entry here for a bounce with multiple catalysts pending. A stop just below Fib. support may be a good idea.